Projects per year
Personal profile
Education
- 1997-2004 M.D., Faculty of Medicine, National Yang-Ming University
Experience
- 2022.08- Director, Division of Hematology, School of Medicine, College of Medicine, Taipei Medical University
- 2020.09- Director, Division of Hematology, Department of Medial Internal Medicine, Taipei Medical University Shuang Ho Hospital
- 2019.08- Assistant Professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2013.02-2019.07 Instructor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2012- Chief of hemato-oncology ward of Shuang-Ho Hospital
- 2012- Chief of Safety of chemotherapeutic agent sub-team of Cancer committee of Shuang Ho Hospital
- 2011- Lecturer, school of medicine, Taipei Medical University
- 2011.09-2012.07 Lecturer, National Yang-Ming University, school of medicine
- 2010.11- Visiting Staff of Shuan-ho Hospital, Department of internal medicine, Division of Hematology and Oncology
- 2010.10-2010.11 Visiting Staff of Taipei Veterans General Hospital, Department of internal medicine, Division of Hematology and Oncology
- 2007-2010 Chief resident of Taipei Veterans General Hospital, Department of internal medicine, Division of Hematology and Oncology
- 2004-2007 Resident doctor of Taipei Veterans General Hospital
- 2002 Official Committee of August Meeting 2002 of International Federations of Medical Students Association
- 2002 Visiting student to Tromsoe University, Tromsoe, Norway
Awards
- 2009 Hsieh YY, Liu CY, Lin HN, Liu JH, Gau JP, Hsiao LT, Yu YB, Chiou TJ, Chen PM, Tzeng CH. Hematopoietic Stem Cell Transplantation (HSCT) for Cytogenetically Normal AML Patients at First Complete Remission-experience from Taipei Veterans General Hospital. The 14th APBMT, outstanding poster award
Research Interests
- Clinical trial
- clinical data mining of Gastrointestinal tract cancer
- drug resistance of chemotherapeutic drug in gastrointestinal tract cancer
Fingerprint
Dive into the research topics where Yao-Yu Hsieh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究－靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果(1/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
布鲁頓酪氨酸激酶(Bruton's tyrosine kinase , BTK)對頑固型耐藥食道癌細胞鐵死亡敏感性之機制研究
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Repurposing of a Positive Allosteric Modulator of M5 Muscarinic Acetylcholine Receptor as a Microtubule-Targeting Agent and Its Application for Treating Pancreatic Ductal Adenocarcinoma
1/1/19 → 6/1/20
Project: A - Government Institution › b - National Science and Technology Council
-
EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements
Nam, M. H., Hsieh, Y. Y. & Chen, B. J., Aug 2022, In: Pathology. 54, 5, p. 634-636 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Long Non-Coding RNA MIR31HG Promotes the Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells
Ko, C. C., Hsieh, Y. Y. & Yang, P. M., Jun 2022, In: International journal of molecular sciences. 23, 12, 6559.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 calcium-binding protein A4 (S100A4)
Hsieh, Y. Y., Cheng, Y. W., Wei, P. L. & Yang, P. M., Aug 2022, In: Toxicology and Applied Pharmacology. 449, 116134.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
High-grade b-cell lymphoma (Hgbl) with myc and bcl2 and/or bcl6 rearrangements is predominantly bcl6-rearranged and bcl6-expressing in Taiwan
Tsai, C. C., Su, Y. C., Bamodu, O. A., Chen, B. J., Tsai, W. C., Cheng, W. H., Lee, C. H., Hsieh, S. M., Liu, M. L., Fang, C. L., Lin, H. T., Chen, C. L., Yeh, C. T., Lee, W. H., Ho, C. L., Lai, S. W., Tzeng, H. E., Hsieh, Y. Y., Chang, C. L., Zheng, Y. M., & 4 others, Apr 1 2021, In: Cancers. 13, 7, 1620.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
ABL genomic editing sufficiently abolishes oncogenesis of human chronic myeloid leukemia cells in vitro and in vivo
Chen, S. H., Hsieh, Y. Y., Tzeng, H. E., Lin, C. Y., Hsu, K. W., Chiang, Y. S., Lin, S. M., Su, M. J., Hsieh, W. S. & Lee, C. H., May 29 2020, In: Cancers. 12, 6, 1399.Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus)
Datasets
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T. (Contributor), Hsieh, Y. (Contributor), Chou, C. (Contributor) & Yang, P. (Contributor), Unknown Publisher, Jan 1 2018
DOI: 10.6084/m9.figshare.7375601.v1, https://rs.figshare.com/articles/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7375601/1
Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
Liu, T. (Contributor), Yang, P. (Creator), Hsieh, Y. (Creator) & Chou, C. (Contributor), The Royal Society, 2018
DOI: 10.6084/m9.figshare.7346312.v2, https://doi.org/10.6084%2Fm9.figshare.7346312.v2
Dataset
-
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T. (Contributor), Hsieh, Y. (Creator), Chou, C. (Contributor) & Yang, P. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v2, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/2
Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T. (Contributor), Hsieh, Y. (Contributor), Chou, C. (Contributor) & Yang, P. (Contributor), Unknown Publisher, Jan 1 2018
DOI: 10.6084/m9.figshare.7346312.v1, https://rs.figshare.com/articles/journal_contribution/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7346312/1
Dataset
-
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T. (Contributor), Hsieh, Y. (Creator), Chou, C. (Contributor) & Yang, P. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v1, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/1
Dataset